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Particle therapy uses proton or 12C beams for the treatment of deep-seated solid tumors. Due to
the features of energy deposition of charged particles a small amount of dose is released to the
healthy tissue in the beam entrance region, while the maximum of the dose is released to the tumor
at the end of the beam range, in the Bragg peak region. However nuclear interactions between
beam and patient tissues induce fragmentation both of projectile and target and must be carefully
taken into account.
In 12C treatments the main concern are long range fragments due to projectile fragmentation that
release dose in the healthy tissue after the tumor, while in proton treatment the target fragmenta-
tion produces low energy, short range fragments along all the beam range.
The FOOT experiment (FragmentatiOn Of Target) is designed to study these processes. Target
nuclei (16O,12C) fragmentation induced by 150-250 AMeV proton beam will be studied via in-
verse kinematic approach. 16O,12C therapeutic beams, with the quoted kinetic energy, collide on
graphite and hydrocarbons target to provide the cross section on Hydrogen. This configuration
explores also the projectile fragmentation of these 16O,12C beams. The detector includes a mag-
netic spectrometer based on silicon pixel detectors, a scintillating crystal calorimeter with TOF
capabilities, able to stop the heavier fragments produced, and a ∆E detector to achieve the needed
energy resolution and particle identification.
An alternative setup of the experiment will exploit the emulsion chamber capabilities. A specific
emulsion chambers will be coupled with the interaction region of the FOOT setup to measure the
production in target fragmentation of light charged fragments as protons, deuterons, tritons and
Helium nuclei.
The FOOT data taking is foreseen at the CNAO experimental room and will start during early
2018 with the emulsion setup, while the complete electronic detector will take data since 2019
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1. Introduction
In the last decade a continuous increase in the number of cancer patients treated with Charged
Particle Therapy (CPT) [1] has been registered, due to its effectiveness in the treatment of deep-
seated solid tumors [2]. At the end of 2014 more than 137000 patients received CPT, mostly with
protons (86%) and with carbon ions (11%). Interest is recently arising in the use of helium and
oxygen as therapeutic ions. The depth-dose profile of charged particles is characterized by an
entrance channel where a low amount of dose is released, followed by a narrow region, the Bragg
Peak (BP), where the maximum of the dose is deposited and that is usually seated on the cancer
region, allowing sparing healthy tissues. Furthermore the increase in Linear Energy Transfer (LET)
at the end of range produces an enhanced biological effectiveness in cell killing in the BP region
compared to conventional photon radiation. This effect is particularly efficient for 12C beam. In
biophysics the Relative Biological Effectiveness (RBE), ratio of photon to charged particle dose
producing the same biological effect, quantifies this effectiveness. Even though track structure also
plays a role, as a general approximation, high LET corresponds to high RBE.
In proton treatment, due to low LET and to high energy of the proton beam in the entrance
channel, a RBE close to one would be expected. Actually, a constant RBE equal to 1.1 is currently
assigned to protons in treatment planning. However, the experiments show a significant increase in
RBE above 1.1 [3] and the topic of RBE variability in protontherapy has been widely debated in
recent years. In particular, as shown in ref. [4], the increase of RBE can give rise to a biological
range extension after BP or to an increase of biological damage in the entrance channel (plateau
region in the Bragg curve), i.e. in the region of healthy tissues. In fact it emerges that using a
constant RBE=1.1 can lead to an under or overestimation of the dose in the healthy tissue region.
An hypothesis proposed in ref. [4] is that particles produced in target fragmentation could be
one of the causes contributing to the increase of RBE of protons. When crossing the patient, nuclear
interactions occur between the beam and the patient tissues. In the case of proton beams, only target
fragmentation occurs, generating a spectrum of low energy heavy recoils that depends on beam
energy and on target materials. These secondary charged particles have short range (e.g. order of
10-100 µm), very high LET and then high RBE. For heavier ion beams, projectile fragmentation
also takes place and is responsible for the dose tail observed after the BP.
The process of target fragmentation can have an impact in particular in the plateau region,
where is estimated almost 10% of proton interactions capable of killing cells are due to nuclear
interactions, while this fraction reduces to 2% in the BP region [4]. A radiobiological model
(LEM [7]) was used to estimate cell survival probability. The expected contribution of target frag-
ments is calculated assuming that in water about 1% of primary protons undergo nuclear inelastic
interactions per traversed cm. Even though both the contributions of ionization and fragmenta-
tion increase when approaching the Bragg peak, at that position the biological effect is mainly due
to ionization events. On the contrary, in the entrance channel the predicted survival is high, and
therefore a significant role might be played by low-energy target fragments.
The lack of information about the impact of target fragmentation on the RBE in CPT is due
on the one hand to the difficult determination of the RBE of fragments with biological experiments
and in the other hand to the lack of cross section data for the production of heavy recoils after


















The Foot (Fragmentation Of Target) Experiment V. Patera
order to address the problem of possible increased effectiveness of protons in the entrance channel,
target fragmentation should be investigated in the energy range 100-250 MeV.
In the energy range of therapeutic application (50-250 MeV for protons and 50-400 MeV/u for
carbon ions) the fragmentation process has not been completely covered by experimental measure-
ments and it is necessary to rely upon simulation models. These suffer from many uncertainties
since there is no exact calculable theory of these nuclear processes. In recent years some ex-
periments have been dedicated to the study of projectile fragmentation of 12C ions, however this
program was carried out only for a few energies [5, 6]. On the other hand the process of target frag-
mentation, which is the only relevant process of this kind in proton therapy, so far has been almost
completely neglected. Actually there are some measurements of light fragment (A<3) production,
but there is a total lack data for larger A values.
2. The FOOT experiment
The main experimental difficulty in the measure of the target fragmentation induced by proton
beams is due to the short ranges of produced fragments that have low probability to escape the
target. In fact their range is confined to tens of microns and even a very thin solid target can
badly spoil the fragment energy measurement. A possible workaround can be envisaged in the
use of gases target but an inverse kinematic approach can be pursued, studying the fragmentation
of different ions beams (C, O, Ca, etc.) onto hydrogen enriched target, such as CH2, as already
adopted in ref.[8, 5]. Secondary fragments will have boosted energy and longer range, making
detection easier. The authors of ref. [5] have already shown that the cross section on H can be
extracted by subtraction from the coupled data obtained using both CH2 and pure C target.
The final goal of the experiment would be to measure the heavy fragment (Z>3) cross section
with maximum uncertainty of 5% and the fragment energy spectrum ( in the "patient" reference
frame) with an energy resolution of the order of 1-2 MeV/u, in order to contribute to a better radio-
biological characterization of protons. The charge and isotopic identification ( at the level of 2-3%
and 5% respectively) are also the main ingredients of this measurement. In spite that fragmentation
nuclear models embedded in simulation software are not reliable to produce sound radiobiological
outcome, Monte Carlo simulation can be safely used as guide for the detector design. An example
of the prediction from Monte Carlo calculation is given in Fig. 1, where the angular distribution
of different fragments produced by a 200MeV/u 16O beam impinging on a CH2 target is shown as
resulting from the FLUKA code [9]. The typical kinematics of the fragmentation in this energy
range is clearly shown: the heavier fragment (Z ≥ 2) are forward peaked within an angular cone
' 100 around the beam and with a kinetic energy per nucleon peaked around the corresponding
value of the beam, while the light fragments have wider angular and kinetic energy distribution.
Due to the particular interest of the heavier fragment the experiment is focused on the detection of
these higher Z fragments in a narrow cone (' 100) around the beam.
Furthermore, analyzing data in terms of direct kinematics, one can also extend and complete
the measurements of projectile fragmentation cross sections induced by C and O beams. Such
measurements are needed to improve the projectile fragmentation description of these beams in ion
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The experimental setup has been designed in order to be easily movable (“table top setup”) and fit the space limitations set
by the different experimental and treatment rooms available in the LNS and HIT facilities were the ion beams of therapeutic
energies are available. A good balancing between the detector cost, its portability and the quest for the largest possible
geometrical acceptance for the heavy-forward fragments reconstruction is found by using a magnetic spectrometer
composed by a permanent magnet preceded and followed by high precision silicon pixellated trackers.
The experiment setup in the downstream direction is made by: a start counter (SC) detector to measure the incoming rate of
beam ions and to provide the start time for the Time of Flight measurements for the fragments; a Drift chamber beam
monitor (BM) providing the beam direction; a set of thin C and CH targets, a silicon detector (Front Silicon Pixel Tracker,
FSPT, based on the MIMOSA[3] technology), a permanent magnet, a second layer of pixel silicon detectors (Rear Silicon Pixel
Tracker, RSPT) for tracking purposes and a pixellated LSO calorimeter preceded by two thin plastic scintillating layers. The
figure shows, not to scale, a possible sketchy experimental setup.
Figure 1: MC al ulation [9] of the angular distribution of different fragments produ ed by a 200MeV/u
16O beam i pinging on a CH2 target.
The measurements performed with the proposed experiment could be also interesting for other
applications, like radioprotection in space. NASA and other space agencies have started since
several years the study of the risk assessment for astronauts in view of long duration space missions,
such for instance the travel to Mars [10]. Beyond many important risks of other nature, both
galactic cosmic rays and particles from the almost unpredictable Solar Particle Events have to be
considered. The design and optimization of spacecraft shielding requires a detailed knowledge of
fragmentation processes.
3. The FOOT detector
The design of the detector is driven mainly by the radiobiology outcome requests. In particular
the adoption of the inverse kinematics approach asks not only for a few % level accuracy on the
energy and of momenta of the produced fragments, but also for a resolution on the emission angle
with respect to the beam of the order of few mrad. To achieve such an angular resolution, both the
beam particles direction before the target and the fragment emission angle after the target must be
tracked with an angular accuracy at the mrad level. Furthermore the multiple scattering angle of
beam+fragment couple inside the target must be kept as well below the mrad. This sets a severe
limit on the allowed thickness of the target (of the order of 1− 2mm ) and limits accordingly the
probability of the fragmentation events to order of 10−3.
The driving criterion of the FOOT detector design is the need for a robust charge and isotopic
identification of the produced fragments. According to this the setup measures the following quan-
tities of the fragments produced: momentum, kinetic energy, Time Of Flight (TOF) and dEdx . Using
these informations the charge can be identified by the crossing of the dEdX measurement with TOF
or kinetic energy, while the mass can be extracted by means of the three kinematic constraints:
p = mcβγ Ekin = mc2(γ−1) Ekin =
√
p2c2−m2c4−mc2 (3.1)
where β = vc and γ =
1√
1−β 2
are derived by the TOF of the fragment.
The fragmentation contribution due to detector material must be kept as low as possible and
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the needed beams at the therapeutic centre like CNAO or HIT . As a consequence the overall size
of the detector should be in the 1.5-2 meters range.
Even with this redundancy on the mass measurement, the needed fragment identification asks
for a detector with the following performances: i) relative resolution on the momentum σ(p)/p
at level of 3%; ii) TOF resolution of the order of 100 ps; iii) relative resolution on the kinetic
energy measurement σ(Ekin)/(EKin) at level of 2%; iv) relative resolution of the ∆E measurement
σ(∆E)/(∆E) at level of 2%;
The detector design, following the beam direction, can be divided in three different regions:
the upstream/target region, the magnetic tracking region and the calorimeter region. A schematic
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Figure 2: Schematic view of the FOOT apparatus.
• The upstream/target region. Here the beam crosses a thin plastic scintillator counter (250µm)
that provides trigger information and the start of the TOF. Then a drift chamber acts as beam
monitor and tracks the direction and the position of the beam. The target is the last element
of this region
• The magnetic region. After the production in the target the fragments enter in a magnetic
region. The magnetic field is provided by two permanent dipole magnets (Halbac geometry).
Before the first magnet, between the magnet and after the second magnet, the fragment di-
rection is measured respectively by two silicon pixel trackers and a drift chamber to extract
the fragment momentum
• The calorimeter region. After the magnetic region the fragments travel 1 meter to reach


















The Foot (Fragmentation Of Target) Experiment V. Patera
scintillator rods. Finally the fragments kinetic energy is measured in a 10 cm thick BGO
crystal calorimeter. The 20 cm radius of the calorimeter is dictated by the angular aperture
of the heavy fragments.
The multiple measurements of the mass allows to keep under control the effect of the neutron punch
through in the calorimeter, that at this energy is present in a sizeable fraction of the events.





































Figure 3: Scheme of the emulsion spectrometer.
The emulsion spectrometer supplies complementary measurements for low Z (Z≤3) particles
and for large angle fragments [11, 12] with respect to the electronic detector previously described.
The emulsion detector allows to extend the fragments maximum angular acceptance from 10 de-
grees up to about 70 degrees with respect the beam axis. The emulsion consists of AgBr crystal
scattered in a gelatine binder. The crystals have a diameter of 0.2 µm and are sensitive to Min-
imum Ionizing Particles (MIPs). The trajectory of a MIP is recorded by a series of sensitised
AgBr crystals along its path acting as latent image centres. A chemical process, known as devel-
opment, enhances latent images, inducing the growth of silver clusters (grains) with a diameter of
0.6 µm which can be seen with an optical microscope. The density of grains is proportional to the
charge particle ionization within the dynamical range. Besides the sub-micrometric space resolu-
tion, another important features of these detectors is that they allow passive and active detector to
be integrated in a very compact set-up, so to make the reconstruction of the interactions inside the
target possible.
The emulsion spectrometer, based on the concept of Emulsion Cloud Chamber (ECC), will
be designed with passive material as carbon target alternated to nuclear emulsions films, acting as
both high-resolution tracking devices and ionization detectors. It is planned to be made of three
sections (Fig. 3): vertex and tracking detector, ionization detector for charge identification and
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The emulsion chamber must be run inside the FOOT setup after the upstream/region part of
the detector, with the start counter and beam monitor used for absolute flux normalization. To
avoid local pile-up the emulsion camber will be exposed to the beam with a remotely controlled
movement system during the data taking.
5. Conclusion and future schedule
As we stated before the issue of the proton RBE (and of the target fragmentation) is under
the spot in the Particle Therapy community, and the FOOT collaboration is designing a detector
to measure both target fragmentation in proton therapy than projectile fragmentation in carbon
therapy. The R&D for experiment during 2017 has been approved and funded by INFN, with
contribution by Centro Fermi Institute. Final approval for the 2018-2021 period expected in june
2017.
The data taking will take place using C,O (N) beams in the 100-350 MeV/u energy range.
Further important features of the experimental site could be the possibility to mount and calibrate
the experimental setup before data taking for long time (1-2 week), beam time availability in the
week range. The preferred site is the experimental hall of the CNAO center in Pavia,Italy, [?] and
a possible data for the first data taking is late 2018 for the emulsion setup, while late 2019 is the
target data taking data for the complete setup
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